Clinical Trial News and Research

RSS
Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Benitec to conduct phase I/II clinical trial of TT-034 in patients with HCV in UCSD site

Benitec to conduct phase I/II clinical trial of TT-034 in patients with HCV in UCSD site

NeuroDerm enrolls patients for Phase IIa clinical trial of ND0612

NeuroDerm enrolls patients for Phase IIa clinical trial of ND0612

Death of heart tissue could be prevented with new medicines, say TUSM scientists

Death of heart tissue could be prevented with new medicines, say TUSM scientists

FDA accepts Otsuka Pharmaceutical's tolvaptan NDA for priority review

FDA accepts Otsuka Pharmaceutical's tolvaptan NDA for priority review

Researchers suggest web-based tools to recruit study participants for clinical pain trials

Researchers suggest web-based tools to recruit study participants for clinical pain trials

Navidea presents Phase 3 Lymphoseek study results at international symposium in Athens

Navidea presents Phase 3 Lymphoseek study results at international symposium in Athens

UCLA physicians perform new procedure to clear plaque-ridden carotid arteries

UCLA physicians perform new procedure to clear plaque-ridden carotid arteries

Nalmefene can provide important clinical benefit for alcohol-dependent patients

Nalmefene can provide important clinical benefit for alcohol-dependent patients

Research on soy-based treatment for colorectal cancer presented at AACR annual meeting

Research on soy-based treatment for colorectal cancer presented at AACR annual meeting

Sorbent Therapeutics starts patient dosing in Phase 2b clinical trial of CLP-1001

Sorbent Therapeutics starts patient dosing in Phase 2b clinical trial of CLP-1001

Gabriel Hortobagyi recognized with AACR-MICR Jane Cooke Wright Lectureship

Gabriel Hortobagyi recognized with AACR-MICR Jane Cooke Wright Lectureship

OncoMed highlights progress of anti-cancer biologics at AACR annual meeting

OncoMed highlights progress of anti-cancer biologics at AACR annual meeting

DelMar Pharmaceuticals reports positive results from VAL-083 Phase I/II clinical trial in patients with GBM

DelMar Pharmaceuticals reports positive results from VAL-083 Phase I/II clinical trial in patients with GBM

First-in-humans study introduces next generation cell therapy for heart failure patients

First-in-humans study introduces next generation cell therapy for heart failure patients

Finding avoids needless exposure to potentially toxic treatment

Finding avoids needless exposure to potentially toxic treatment

Phase I results show Rogosertib is well tolerated in patients with advanced solid tumors

Phase I results show Rogosertib is well tolerated in patients with advanced solid tumors

Researchers evaluate Pexa-Vec to slow progression of liver cancer

Researchers evaluate Pexa-Vec to slow progression of liver cancer

Galectin Therapeutics provides details on first-in-man Phase 1 clinical trial of GR-MD-02

Galectin Therapeutics provides details on first-in-man Phase 1 clinical trial of GR-MD-02

Boehringer Ingelheim's STARTVerso 1 Phase 3 hepatitis C data to be presented at EASL Congress

Boehringer Ingelheim's STARTVerso 1 Phase 3 hepatitis C data to be presented at EASL Congress

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.